Desert Immune Phenotype in Endometrial Carcinoma: A Distinct Subgroup With Poor Prognosis and Targetable Mutations.
Saved in:
| Title: | Desert Immune Phenotype in Endometrial Carcinoma: A Distinct Subgroup With Poor Prognosis and Targetable Mutations. |
|---|---|
| Authors: | Kaya M; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Lin LH; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Oosting J; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Powell ME; Department of Clinical Oncology, Barts and The London NHS Trust, London, United Kingdom., Davidson EJ; Gynaecological Oncology Research Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St. Mary's Hospital, Manchester, United Kingdom; Department of Obstetrics and Gynaecology, St. Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; Centre for Reproductive Health, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK; CRUK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK., Leary A; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Mileshkin LR; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia., Shepherd L; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada., de Bruyn M; Department of Obstetrics and Gynaecology, University Medical Centre Groningen, Groningen, The Netherlands., Jobsen J; Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands., Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Creutzberg CL; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands., Horeweg N; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands., Léon-Castillo A; Department of Pathology, Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Parra-Herran C; Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Smit VTHBM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Nucci MR; Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Bosse T; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: T.Bosse@lumc.nl. |
| Source: | Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2026 Jun; Vol. 39 (6), pp. 101000. Date of Electronic Publication: 2026 Apr 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41967711 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Desert Immune Phenotype in Endometrial Carcinoma: A Distinct Subgroup With Poor Prognosis and Targetable Mutations. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kaya+M%22">Kaya M</searchLink>; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Lin+LH%22">Lin LH</searchLink>; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Oosting+J%22">Oosting J</searchLink>; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Powell+ME%22">Powell ME</searchLink>; Department of Clinical Oncology, Barts and The London NHS Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Davidson+EJ%22">Davidson EJ</searchLink>; Gynaecological Oncology Research Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St. Mary's Hospital, Manchester, United Kingdom; Department of Obstetrics and Gynaecology, St. Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; Centre for Reproductive Health, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK; CRUK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Leary+A%22">Leary A</searchLink>; Department of Medical Oncology, Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Mileshkin+LR%22">Mileshkin LR</searchLink>; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Shepherd+L%22">Shepherd L</searchLink>; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22de+Bruyn+M%22">de Bruyn M</searchLink>; Department of Obstetrics and Gynaecology, University Medical Centre Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Jobsen+J%22">Jobsen J</searchLink>; Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kroep+JR%22">Kroep JR</searchLink>; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Creutzberg+CL%22">Creutzberg CL</searchLink>; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Horeweg+N%22">Horeweg N</searchLink>; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Léon-Castillo+A%22">Léon-Castillo A</searchLink>; Department of Pathology, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Parra-Herran+C%22">Parra-Herran C</searchLink>; Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Smit+VTHBM%22">Smit VTHBM</searchLink>; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Nucci+MR%22">Nucci MR</searchLink>; Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Bosse+T%22">Bosse T</searchLink>; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: T.Bosse@lumc.nl. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228806605%22">Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc</searchLink> [Mod Pathol] 2026 Jun; Vol. 39 (6), pp. 101000. <i>Date of Electronic Publication: </i>2026 Apr 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8806605 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1530-0285 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208933952%22">08933952 </searchLink><i>NLM ISO Abbreviation: </i>Mod Pathol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41967711 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.modpat.2026.101000 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 101000 Titles: – TitleFull: Desert Immune Phenotype in Endometrial Carcinoma: A Distinct Subgroup With Poor Prognosis and Targetable Mutations. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kaya M – PersonEntity: Name: NameFull: Lin LH – PersonEntity: Name: NameFull: Oosting J – PersonEntity: Name: NameFull: Powell ME – PersonEntity: Name: NameFull: Davidson EJ – PersonEntity: Name: NameFull: Leary A – PersonEntity: Name: NameFull: Mileshkin LR – PersonEntity: Name: NameFull: Shepherd L – PersonEntity: Name: NameFull: de Bruyn M – PersonEntity: Name: NameFull: Jobsen J – PersonEntity: Name: NameFull: Kroep JR – PersonEntity: Name: NameFull: Creutzberg CL – PersonEntity: Name: NameFull: Horeweg N – PersonEntity: Name: NameFull: Léon-Castillo A – PersonEntity: Name: NameFull: Parra-Herran C – PersonEntity: Name: NameFull: Smit VTHBM – PersonEntity: Name: NameFull: Nucci MR – PersonEntity: Name: NameFull: Bosse T IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1530-0285 Numbering: – Type: volume Value: 39 – Type: issue Value: 6 Titles: – TitleFull: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Type: main |
| ResultId | 1 |